hCCR8

品系全名

C57BL/6JSmo-Ccr8tm1(hCCR8) Smoc

目录号

NM-HU-190053

品系状态

胚胎冻存

导出PDF

基因信息

基因名
CCR8

品系描述

通过同源重组,将小鼠基因Ccr8进行人源化修饰。与此相似的品系还有hCCR8(2)(NM-HU-2000054),详细信息请咨询技术顾问。
应用领域:免疫治疗;肿瘤研究;药物筛选

验证数据

CCR8-HU-1.pngCCR8-HU-2.png

Fig1. 流式检测 CCR8 人源化小鼠血液中各类免疫细胞的比例。

CCR8-HU-3.png

Fig2. 流式检测 CCR8 人源化小鼠脾脏中免疫细胞的总比例。

CCR8-HU-4.png

Fig3. 流式检测 CCR8 人源化小鼠中 CCR8 的表达。

CCR8-HU-5.png

CCR8-HU-6.png


Fig4. 流式检测  CCR8 人源化小鼠的 T 细胞与 CCR8 抗体药物的结合效率。


图片1.png

图5. hCCR8抗体(anti-hCCR8)可以抑制CCR8人源化小鼠上MC38-OVA移植瘤的生长和浸润。(A)给药方案示意图; (B) 平均肿瘤体积和个体肿瘤体积; (C) anti-hCCR8治疗后肿瘤浸润 CCR8+ Treg细胞的情况(蓝绿色为对照组,黄色为anti-hCCR8治疗组)。(与Crownbio合作完成) 


2.png

图6. hCCR8抗体(anti-hCCR8)可以抑制CCR8人源化小鼠上Hepa1-6移植瘤的生长和浸润。(A)给药方案示意图; (B) 平均肿瘤体积和个体肿瘤体积; (C) anti-hCCR8治疗后肿瘤浸润 CCR8+ Treg细胞的情况(蓝绿色为对照组,黄色为anti-hCCR8治疗组)。(与Crownbio合作完成)


你也可能感兴趣

Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute

On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.

查看

Workshop:Progress and Advances in Preclinical immuno-Oncology Research

SMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.

查看

Customizing Mouse Models: Delivering in 100 Days to Speed Up Your Research!

At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.

查看